A total of 236 marine microbial metabolites were evaluated for their DPPH⋅ (1,1-diphenyl-2-picrylhydrazyl) radical scavenging activity. Initial assay showed that 27 compounds at 100 µM had radical scavenging activity in different degrees with RSA% values of 53.93–99.00%. Further testing revealed that 13 compounds had potent activity with IC50 values of 4.94–18.64 µM, including peniciphenalenin F (53), asperindopiperazine A (82), asperindopiperazine C (83), 2-deisoprenyl-neoechinulin A (84), dipodazine (85), 20 R,25S-preshamixanthone (100), phthalimidinic acid A (104), 2-hydroxyemodic acid (105), asperthecin (106), talamin A (120), 2-aminobenzamide (146), isodihydroauroglaucin (231), and flavoglaucin (232). Asperindopiperazine C (83), dipodazine (85), 2-hydroxyemodic acid (105), talamin A (120), isodihydroauroglaucin (231), and flavoglaucin (232) were six most active compounds with IC50 values of 4.94–9.86 µM, which were stronger than or equivalent to that of the control ascorbic acid (IC50: 9.56 µM). These identified compounds show promising in vitro radical-scavenging activity and warrant further investigation using complementary antioxidant assays and appropriate cellular or biological models.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: